Quick Answer
BELITE BIO, INC reported Stockholders Equity of $770.49 million for fiscal year 2025.
BELITE BIO, INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $770.49M | +428.4% |
| 2024 | $145.82M | +61.3% |
| 2023 | $90.43M | +117.9% |
| 2022 | $41.50M | +375.0% |
| 2021 | -$15.09M | -114.5% |
| 2020 | -$7.04M | -88.2% |
| 2019 | -$3.74M | — |
- BELITE BIO, INC showed an increase of +428.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, BELITE BIO, INC’s stockholders equity has grown by 20706.7% (from -$3.74 million to $770.49 million).
- The most recent figure is from BELITE BIO, INC’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: